CA
OSCR icon

Continuum Advisory’s Oscar Health OSCR Stock Holding History

Continuum Advisory’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-49
Closed -$775 – 1987
2024
Q2 		$775 Buy
+49
New +$901 ﹤0.01% 1520

Other funds holding OSCR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Continuum Advisory's OSCR Position: Q3 2024 in Review

Continuum Advisory sold out of Oscar Health (OSCR) in Q3 2024, closing a stake of 49 shares — an estimated $775 sold.

Continuum Advisory first reported a position in OSCR in Q2 2024 and held it in 1 quarter. The position peaked at $775 in Q2 2024. 284 funds tracked by Wall St. Rank hold OSCR as of Q3 2024.

  • Continuum Advisory reported no remaining Oscar Health position as of Q3 2024 after selling out during the quarter.
  • Continuum Advisory sold 49 Oscar Health shares in Q3 2024, an estimated $775.
  • Continuum Advisory first reported a position in Oscar Health in Q2 2024 and held it in 1 quarter.
  • Continuum Advisory's Oscar Health position peaked at $775 in Q2 2024.
  • 284 funds tracked by Wall St. Rank held Oscar Health as of Q3 2024.

Based on Continuum Advisory's 13F filing for Q3 2024, filed 15 Nov 2024.